Why Tapering Is Great News for Allergan Inc.

How growth stocks like Allergan could benefit from tapering.

Jan 6, 2014 at 8:15PM

The U.S. economy is in better shape than it was a few months back and in even better shape than it was at the start of 2013. Not only is this good news for families across the U.S., but it's also awesome news for growth stocks like Allergan (NYSE:AGN).

That's because growth stocks tend to perform well during the more prosperous parts of the business cycle, when consumer confidence is improving and households across America are spending more and more. In addition, the risk premiums attached by the market to growth stocks like Allergan are also reduced, meaning future cash flows are discounted at a lower rate -- which, in turn, means a higher valuation. This is great news for shareholders.

Of course, not all stocks are affected to the same extent, but the signs appear to be encouraging for Allergan. It is now forecast to deliver earnings-per-share growth of 31% in the year to Dec. 31, 2013, and 14% in the year to Dec. 31, 2014.

This equates to a compound annual growth rate of 22.2%, which marks Allergan as a seriously hot growth stock. Furthermore, if the U.S. economy continues to improve at the rate it's been doing in recent months, upgrades to EPS forecasts could be possible, with a proportion of Allergan's sales being discretionary rather than staples.

This is a point worth noting. Unlike many of its sector peers, which exclusively sell drugs that patients need to get better, Allergan also sells products such as botox, which -- although sometimes needed for the treatment of conditions such as upper limb spasticity -- isn't always a necessity.

Therefore, it could be argued that further improvements in the outlook for U.S. household budgets may mean increased demand for discretionary health-care products such as botox, with Allergan being a possible net gainer.

Of course, Allergan's fundamentals also allow it to hold its own when pitted against sector rivals such as Merck (nyse: mrk) and Pfizer (nyse: pfe). For instance, Allergan's return on equity in 2012 was a very encouraging 18.8%, and with the previously mentioned growth prospects still to come, 2013 and 2014 could be even better.

Allergan's return on equity compares favorably with that of Merck and Pfizer. Their most recent return on equity figures were 11.4% and 11.6%, respectively, although both companies are set to grow earnings at a slightly faster pace than Allergan in 2013 and 2014 (combined), so the gap should narrow somewhat, although Allergan should still be out in front.

Such comparisons highlight the attraction of Allergan as opposed to highlighting the weaknesses of Merck and Pfizer, both of which are exciting pharmaceutical stocks in their own right.

However, it does appear as though Allergan is well positioned to benefit from an improving U.S. economy, having the potential for upgrades to its already highly impressive growth forecasts.

The discretionary nature of its products may also give it a boost as the U.S. economy goes from strength to strength and tapering really takes hold in 2014 and 2015.

Here's another hot growth stock for 2014
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Fool contributor Peter Stephens and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.


Compare Brokers